COLCHICINE REDUCES MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

被引：0
|
作者：
Fadhil, Ameer
Al Wssawi, Abbas
Gumera, Armand
Hashim, Hashim Talib
Al-Shammari, Ali Saad
Abdeltawwab, Mohannad
Amin, Mahmoud
机构：
[1] Univ Warith Al Anbyiaa, Coll Med, Karbala, Iraq
[2] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1229-164
引用
收藏
页码：919 / 919
页数：1
相关论文
共 50 条
  • [31] Cangrelor or Clopidogrel in Patients with Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Lu, Hongtao
    Guan, Wenjun
    Zhou, Yanhua
    Tang, Zhangui
    Bao, Hong
    DIABETES THERAPY, 2019, 10 (03) : 937 - 950
  • [32] Intracoronary abciximab reduces death and major adverse cardiovascular events in acute coronary syndromes: A meta-analysis of clinical trials
    De Rosa, Salvatore
    Caiazzo, Gianluca
    Torella, Daniele
    Indolfi, Ciro
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 1298 - 1305
  • [33] Statin administration prior to percutaneous coronary interventions reduces adverse cardiovascular events - A meta-analysis
    Ebrahimi, R
    Shah, AP
    Wadhani, N
    Saleh, JR
    Toggart, E
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 155H - 156H
  • [34] Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Sterling, Lee H.
    Windle, Sarah B.
    Filion, Kristian B.
    Touma, Lahoud
    Eisenberg, Mark J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (02):
  • [35] Bisphosphonate and Adverse Cardiovascular Events: Meta-Analysis of Randomized Placebo-Controlled Trials
    Kim, Dae Hyun
    Rogers, James R.
    Fulchino, Lisa A.
    Solomon, Daniel H.
    Kim, Seoyoung C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 446 - 446
  • [36] Statin administration prior to percutaneous coronary interventions reduces adverse cardiovascular events - A meta-analysis
    Ebrahimi, R
    Shah, AP
    Wadhani, N
    Shingate, M
    Toggart, EJ
    Saleh, J
    CIRCULATION, 2005, 112 (17) : U544 - U544
  • [37] High-dose statin pretreatment decreases cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: a meta-analysis of eighteenrandomized controlled trials
    Zhang, B.
    Zheng, B.
    Jia, J.
    Wang, X. G.
    Shi, Q. P.
    Chen, M.
    Huo, Y.
    EUROPEAN HEART JOURNAL, 2017, 38 : 878 - 879
  • [38] Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
    Cai, Anping
    Dillon, Chrisly
    Hillegass, William B.
    Beasley, Mark
    Brott, Brigitta C.
    Bittner, Vera A.
    Perry, Gilbert J.
    Halade, Ganesh V.
    Prabhu, Sumanth D.
    Limdi, Nita A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (22):
  • [39] Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
    Chen, Zhihao
    Jiang, Chaohui
    Qu, Huimin
    Liang, Shuang
    Yang, Jian
    Wu, Hui
    He, Chao
    Wang, Xinan
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (06) : 1375 - 1380
  • [40] Efficacy and safety of bivalirudin vs heparin in patients with coronary heart disease undergoing percutaneous coronary intervention A meta-analysis of randomized controlled trials
    Liu, Xiao-Qiang
    Luo, Xian-Du
    Wu, Yan-Qing
    MEDICINE, 2020, 99 (06)
12345